bf/NASDAQ:CTKB_icon.png

NASDAQ:CTKB

Cytek Biosciences, Inc.

  • Stock

USD

Last Close

6.20

03/05 20:00

Market Cap

1.15B

Beta: -

Volume Today

715.80K

Avg: 1.13M

PE Ratio

−73.77

PFCF: −132.08

Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
account payables
2.34M
-
2.94M
25.70%
3.03M
3.06%
4.80M
58.37%
3.03M
36.90%
accumulated other comprehensive income loss
-147K
-
65K
144.22%
897K
1,280%
-697K
177.70%
-1.27M
82.93%
cash and cash equivalents
30.12M
-
165.23M
448.54%
364.62M
120.67%
296.60M
18.65%
167.63M
43.48%
cash and short term investments
30.12M
-
165.23M
448.54%
364.62M
120.67%
341.15M
6.44%
262.74M
22.98%
common stock
21K
-
23K
9.52%
126K
447.83%
135K
7.14%
131K
2.96%
deferred revenue
3.47M
-
4.29M
23.57%
7.08M
65.10%
12.99M
83.39%
22.70M
74.77%
deferred revenue non current
1.78M
-
3.46M
93.94%
9.79M
183.28%
13.12M
34.06%
15.13M
15.30%
deferrred tax liabilities non current
3.21M
-
goodwill
476K
-
476K
0%
10.14M
2,031.09%
10.14M
0%
16.18M
59.53%
goodwill and intangible assets
739K
-
750K
1.49%
14.88M
1,884.40%
14.47M
2.74%
39.27M
171.27%
intangible assets
263K
-
274K
4.18%
4.74M
1,629.56%
4.33M
8.61%
23.08M
432.99%
inventory
18.43M
-
23.02M
24.87%
32.17M
39.76%
48.15M
49.68%
60.88M
26.42%
long term debt
14.58M
-
18.13M
24.29%
long term investments
1.60M
-
net debt
-30.12M
-
-162.46M
439.34%
-364.62M
124.44%
-278.51M
23.62%
-134.46M
51.72%
net receivables
17.75M
-
18.10M
2.02%
29.76M
64.38%
48.86M
64.19%
56.12M
14.85%
other assets
1
-
other current assets
301K
-
445K
47.84%
5.50M
1,136.63%
12.95M
135.40%
12.32M
4.88%
other current liabilities
8.01M
-
16.53M
106.30%
6.79M
58.90%
27.74M
308.27%
24.93M
10.13%
other liabilities
other non current assets
816K
-
1.09M
33.46%
1.67M
52.89%
2.96M
77.60%
1.78M
39.63%
other non current liabilities
89.24M
-
206.01M
130.85%
14.95M
92.74%
17.18M
14.94%
11.91M
30.69%
othertotal stockholders equity
443K
-
6.49M
1,365.24%
-39.68M
711.31%
-76.59M
93.02%
423.39M
652.80%
preferred stock
463.31M
-
519.48M
12.12%
property plant equipment net
1.04M
-
2.14M
105.57%
5.85M
173.41%
27.57M
371.12%
29.26M
6.14%
retained earnings
-42.02M
-
-22.61M
46.20%
-18.19M
19.54%
-17.03M
6.38%
-29.18M
71.33%
short term debt
7.21M
-
2.77M
61.57%
15.25M
450.18%
3.51M
76.98%
5.57M
58.64%
short term investments
44.55M
-
95.11M
113.50%
tax assets
7.38M
-
9.25M
25.36%
20.46M
121.20%
33.70M
64.71%
tax payables
571K
-
1.03M
81.09%
3.88M
275.15%
1.67M
57.03%
1.30M
22.20%
total assets
70.36M
-
219.98M
212.64%
463.70M
110.79%
519.48M
12.03%
497.67M
4.20%
total current assets
67.77M
-
208.62M
207.86%
432.05M
107.10%
454.02M
5.08%
392.06M
13.65%
total current liabilities
21.04M
-
26.54M
26.13%
32.16M
21.19%
49.04M
52.49%
56.23M
14.65%
total debt
2.77M
-
18.09M
-
33.17M
83.34%
total investments
44.55M
-
96.71M
117.09%
total liabilities
112.06M
-
236.01M
110.60%
56.90M
75.89%
93.93M
65.08%
104.61M
11.36%
total liabilities and stockholders equity
70.36M
-
219.98M
212.64%
463.70M
110.79%
519.48M
12.03%
497.67M
4.20%
total non current assets
2.60M
-
11.36M
337.48%
31.65M
178.67%
65.46M
106.83%
105.61M
61.34%
total non current liabilities
91.02M
-
209.47M
130.13%
24.74M
88.19%
44.89M
81.45%
48.38M
7.77%
total stockholders equity
-41.70M
-
-16.03M
61.56%
406.46M
2,635.92%
425.30M
4.63%
393.06M
7.58%

All numbers in USD (except ratios and percentages)